Norwegian Air Ambulance Foundation Report issue

Foundation Phase 1 Phase 2 Phase 3

Organization Overview

First Clinical Trial
2003
NCT00121524
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Norwegian Air Ambulance Foundation

Active Ingredients

Drugs in Phase 3 Trials (3)

fentanyl (Innovar) (1 trial)

methoxyflurane (penthrane) (1 trial)

morphine (1 trial)

Drugs in Phase 2 Trials (3)

amiodarone (cordarone) (1 trial)

atropine (1 trial)

epinephrine (levophed) (1 trial)

Drugs in Phase 1 Trials (1)

oxygen (1 trial)

Drugs in Other Trials (1)

allogeneic blood cells (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Heart Arrest (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 4
  • # of Trial APIs: 8